1572 related articles for article (PubMed ID: 15838185)
21. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo.
Hindmarch I; Dawson J; Stanley N
Sleep; 2005 Feb; 28(2):187-93. PubMed ID: 16171242
[TBL] [Abstract][Full Text] [Related]
22. Duration of sleep inertia after napping during simulated night work and in extended operations.
Signal TL; van den Berg MJ; Mulrine HM; Gander PH
Chronobiol Int; 2012 Jul; 29(6):769-79. PubMed ID: 22734577
[TBL] [Abstract][Full Text] [Related]
23. An E-health solution for automatic sleep classification according to Rechtschaffen and Kales: validation study of the Somnolyzer 24 x 7 utilizing the Siesta database.
Anderer P; Gruber G; Parapatics S; Woertz M; Miazhynskaia T; Klosch G; Saletu B; Zeitlhofer J; Barbanoj MJ; Danker-Hopfe H; Himanen SL; Kemp B; Penzel T; Grozinger M; Kunz D; Rappelsberger P; Schlogl A; Dorffner G
Neuropsychobiology; 2005; 51(3):115-33. PubMed ID: 15838184
[TBL] [Abstract][Full Text] [Related]
24. Lack of pharmacologic interaction between paroxetine and alprazolam at steady state in healthy volunteers.
Calvo G; García-Gea C; Luque A; Morte A; Dal-Ré R; Barbanoj M
J Clin Psychopharmacol; 2004 Jun; 24(3):268-76. PubMed ID: 15118480
[TBL] [Abstract][Full Text] [Related]
25. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
Uchimura N; Kamijo A; Kuwahara H; Uchiyama M; Shimizu T; Chiba S; Inoue Y
Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
[TBL] [Abstract][Full Text] [Related]
26. Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects.
Feige B; Voderholzer U; Riemann D; Dittmann R; Hohagen F; Berger M
Neuropsychopharmacology; 2002 Feb; 26(2):246-58. PubMed ID: 11790520
[TBL] [Abstract][Full Text] [Related]
27. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
29. Contribution of core body temperature, prior wake time, and sleep stages to cognitive throughput performance during forced desynchrony.
Darwent D; Ferguson SA; Sargent C; Paech GM; Williams L; Zhou X; Matthews RW; Dawson D; Kennaway DJ; Roach GD
Chronobiol Int; 2010 Jul; 27(5):898-910. PubMed ID: 20636204
[TBL] [Abstract][Full Text] [Related]
30. Nonorganic insomnia in panic Disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam.
Saletu-Zyhlarz GM; Anderer P; Berger P; Gruber G; Oberndorfer S; Saletu B
Hum Psychopharmacol; 2000 Jun; 15(4):241-254. PubMed ID: 12404319
[TBL] [Abstract][Full Text] [Related]
31. Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers.
Gillin JC; Lardon M; Ruiz C; Golshan S; Salin-Pascual R
J Clin Psychopharmacol; 1994 Aug; 14(4):264-7. PubMed ID: 7962682
[TBL] [Abstract][Full Text] [Related]
32. Effect of zolpidem on sleep in healthy subjects: a placebo-controlled trial with polysomnographic recordings.
Blois R; Gaillard JM; Attali P; Coquelin JP
Clin Ther; 1993; 15(5):797-809. PubMed ID: 8269446
[TBL] [Abstract][Full Text] [Related]
33. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
34. The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans.
Wilson SJ; Bailey JE; Rich AS; Nash J; Adrover M; Tournoux A; Nutt DJ
J Psychopharmacol; 2005 Nov; 19(6):609-13. PubMed ID: 16272182
[TBL] [Abstract][Full Text] [Related]
35. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome.
Saletu M; Anderer P; Högl B; Saletu-Zyhlarz G; Kunz A; Poewe W; Saletu B
J Neural Transm (Vienna); 2003 Jun; 110(6):611-26. PubMed ID: 12768357
[TBL] [Abstract][Full Text] [Related]
36. Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients.
Feige B; Al-Shajlawi A; Nissen C; Voderholzer U; Hornyak M; Spiegelhalder K; Kloepfer C; Perlis M; Riemann D
J Sleep Res; 2008 Jun; 17(2):180-90. PubMed ID: 18482106
[TBL] [Abstract][Full Text] [Related]
37. Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects.
Mathias S; Zihl J; Steiger A; Lancel M
Neuropsychopharmacology; 2005 Apr; 30(4):833-41. PubMed ID: 15602499
[TBL] [Abstract][Full Text] [Related]
38. Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years.
Diefenbach K; Arold G; Wollny A; Schwantes U; Haselmann J; Roots I
BJU Int; 2005 Feb; 95(3):346-9. PubMed ID: 15679791
[TBL] [Abstract][Full Text] [Related]
39. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
[TBL] [Abstract][Full Text] [Related]
40. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; Shelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Sands S; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2012 Aug; 342(2):429-40. PubMed ID: 22570363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
